I am currently Clinical Associate Professor at the University of Southampton and Honorary Consultant Child Psychiatrist at Solent NHS Trust. I am also Adjunct Associate Professor at the New York University, NY, USA. My research and clinical interests focus on the epidemiology neurobiology and treatment of neurodevelopmental disorders, in particular ADHD. I have published, as first author or co-author, more than 100 peer-reviewed papers in high impact journals, including first author papers in the American Journal of Psychiatry and the British Journal of Psychiatry. I sit on the editorial board of the Journal of the American Academy of Child and Adolescent Psychiatry, The Journal of Child Psychology and Psychiatry, CNS Drugs, the Journal of Child and Adolescent Psychopharmacology, and Attention Deficit Hyperactivity Disorders. I conduct part of my research activity as a member of the European ADHD Guidelines Group. I am the Branch Liaison officer for the Association of Child and Adolescent Mental Health (ACAMH) and member of the ACAMH Southern board.
Samuele Cortese reports on a recent study of 13-25 year old people with ADHD, which looks at the comparative risk of psychosis during treatment with methylphenidate and amphetamines.[read the full story...]
Samuele Cortese is impressed by a recent RCT of QbTest: a computerised test of attention and activity, which can improve diagnostic decision-making in children and young people with suspected ADHD.[read the full story...]
Samuele Cortese considers the findings of a recent nationwide self controlled case series study of the cardiovascular safety of methylphenidate use in children and young people with ADHD.[read the full story...]
Samuele Cortese publishes his debut Mental Elf blog on a meta-analysis of n-of-1 trials, which shows that amphetamine derivatives and methylphenidate are superior to placebo, in the short term, for paediatric ADHD.[read the full story...]